| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | Dec 19, 2025 | Royalty Pharma plc | EVP, Investments & CLO | Sell | 20.0 | -110,000 | -12.36% | ✓ | $4.2M |
| Dec 3, 2025 | Dec 5, 2025 | Royalty Pharma plc | EVP, Investments & CLO | Sell | 20.0 | -110,000 | -11.00% | ✓ | $4.4M |
| Nov 19, 2025 | Nov 21, 2025 | Royalty Pharma plc | EVP, Investments & CLO | Sell | 18.8 | -135,426 | -11.93% | ✓ | $5.2M |
| Jun 2, 2023 | Jun 6, 2023 | Royalty Pharma plc | EVP, Investments & CLO | Sell | 16.3 | -192,221 | -17.18% | ✗ | $6.5M |
| Mar 28, 2023 | Mar 30, 2023 | Royalty Pharma plc | EVP, Investments & CLO | Sell | 17.5 | -112,779 | -9.16% | ✗ | $4.2M |
| Feb 23, 2023 | Feb 27, 2023 | Royalty Pharma plc | EVP, Investments & CLO | Sell | 20.0 | -25,000 | -1.99% | ✗ | $931.7K |
| Nov 21, 2022 | Nov 22, 2022 | Royalty Pharma plc | EVP, Investments & CLO | Sell | 17.5 | -40,000 | -3.08% | ✗ | $1.7M |
| Nov 10, 2022 | Nov 14, 2022 | Royalty Pharma plc | EVP, Investments & CLO | Sell | 32.5 | -50,000 | -3.71% | ✓ | $2.2M |
| Aug 9, 2022 | Aug 11, 2022 | Royalty Pharma plc | EVP, Investments & GC | Sell | 42.5 | -20,854 | -1.51% | ✓ | $915.9K |
| Jul 28, 2022 | Aug 1, 2022 | Royalty Pharma plc | EVP, Investments & GC | Sell | 48.8 | -4,046 | -0.29% | ✓ | $177.9K |
| Jul 25, 2022 | Jul 27, 2022 | Royalty Pharma plc | EVP, Investments & GC | Sell | 32.5 | -75,100 | -3.93% | ✓ | $3.2M |
| May 26, 2022 | May 31, 2022 | Royalty Pharma plc | EVP, Investments & GC | Sell | 17.5 | -100,000 | -6.46% | ✗ | $4M |
| May 23, 2022 | May 25, 2022 | Royalty Pharma plc | EVP, Investments & GC | Sell | 17.5 | -100,000 | -6.07% | ✗ | $4M |
| Nov 16, 2021 | Nov 18, 2021 | Royalty Pharma plc | EVP, Investments & GC | Sell | 15.0 | -250,000 | -13.18% | ✗ | $10.6M |
| Jul 26, 2021 | Jul 27, 2021 | Royalty Pharma plc | EVP, Investments & GC | Sell | 45.0 | -13,362 | -0.70% | ✓ | $531.5K |
| Jul 12, 2021 | Jul 14, 2021 | Royalty Pharma plc | EVP, Investments & GC | Sell | 42.5 | -23,149 | -1.20% | ✓ | $972.5K |
| Jul 6, 2021 | Jul 8, 2021 | Royalty Pharma plc | EVP, Investments & GC | Sell | 32.5 | -88,489 | -4.38% | ✓ | $3.7M |
| Jun 10, 2021 | Jun 14, 2021 | Royalty Pharma plc | EVP, Investments & GC | Sell | 17.5 | -70,000 | -3.35% | ✗ | $3.3M |
| Jun 4, 2021 | Jun 8, 2021 | Royalty Pharma plc | EVP, Investments & GC | Sell | 15.0 | -252,500 | -10.77% | ✗ | $11.6M |
| Jun 2, 2021 | Jun 4, 2021 | Royalty Pharma plc | EVP, Investments & GC | Sell | 36.3 | -62,500 | -2.60% | ✓ | $2.6M |
| Apr 14, 2021 | Apr 16, 2021 | Royalty Pharma plc | EVP, Investments & GC | Sell | 20.0 | -69,822 | -11.70% | ✓ | $2.9M |
| Apr 12, 2021 | Apr 14, 2021 | Royalty Pharma plc | EVP, Investments & GC | Sell | 55.0 | -449 | -0.08% | ✓ | $19K |
| Mar 22, 2021 | Mar 24, 2021 | Royalty Pharma plc | EVP, Investments & GC | Sell | 23.8 | -54,729 | -8.39% | ✓ | $2.5M |
| Mar 2, 2021 | Mar 4, 2021 | Royalty Pharma plc | EVP, Investments & GC | Sell | 13.8 | -125,000 | -16.09% | ✓ | $5.9M |
| Jun 18, 2020 | Jun 22, 2020 | Royalty Pharma plc | EVP, Investments & GC | Buy | 97.5 | +14,200 | 100.00% | ✗ | $397.6K |